Francisco Javier Cubero

5.1k total citations · 1 hit paper
90 papers, 2.9k citations indexed

About

Francisco Javier Cubero is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Francisco Javier Cubero has authored 90 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Epidemiology, 31 papers in Hepatology and 27 papers in Molecular Biology. Recurrent topics in Francisco Javier Cubero's work include Liver Disease Diagnosis and Treatment (39 papers), Liver physiology and pathology (22 papers) and Drug-Induced Hepatotoxicity and Protection (18 papers). Francisco Javier Cubero is often cited by papers focused on Liver Disease Diagnosis and Treatment (39 papers), Liver physiology and pathology (22 papers) and Drug-Induced Hepatotoxicity and Protection (18 papers). Francisco Javier Cubero collaborates with scholars based in Spain, Germany and United States. Francisco Javier Cubero's co-authors include Yulia A. Nevzorova, Natalia Nieto, Christian Trautwein, Raquel Benedé‐Ubieto, Leonard J. Nelson, Christian Liedtke, Jordi Gracia‐Sancho, Zoe Boyer‐Díaz, Kang Zheng and Pierluigi Ramadori and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Francisco Javier Cubero

85 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)

2024 94 citations Raquel Benedé‐Ubieto, Francisco Javier Cubero et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Francisco Javier Cubero Spain	32	1.3k	937	793	455	404	90	2.9k
E. Ceni Italy	25	1.1k 0.9×	906 1.0×	744 0.9×	484 1.1×	357 0.9×	44	2.5k
Laura W. Schrum United States	29	1.3k 1.0×	1.2k 1.2×	1.1k 1.3×	382 0.8×	450 1.1×	67	3.0k
Erwin Gäbele Germany	21	1.4k 1.1×	793 0.8×	890 1.1×	678 1.5×	325 0.8×	29	2.7k
Runping Liu China	33	1.2k 1.0×	1.7k 1.8×	593 0.7×	243 0.5×	589 1.5×	99	3.5k
Shuichi Seki Japan	28	1.4k 1.1×	942 1.0×	1.3k 1.7×	317 0.7×	581 1.4×	129	3.4k
Mikihiro Tsutsumi Japan	31	1.4k 1.1×	728 0.8×	879 1.1×	977 2.1×	358 0.9×	126	2.9k
Narci Teoh Australia	30	2.0k 1.5×	1.4k 1.5×	1.1k 1.4×	409 0.9×	955 2.4×	50	3.8k
Xiaojiaoyang Li China	33	1.1k 0.8×	1.6k 1.7×	542 0.7×	196 0.4×	442 1.1×	98	3.4k
Xiaoni Kong China	32	1.3k 1.0×	1.7k 1.9×	902 1.1×	390 0.9×	651 1.6×	114	4.4k
Bryan L. Copple United States	31	1.5k 1.2×	1.1k 1.1×	1.1k 1.3×	179 0.4×	606 1.5×	59	3.5k

Countries citing papers authored by Francisco Javier Cubero

Since Specialization

Citations

This map shows the geographic impact of Francisco Javier Cubero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Javier Cubero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Javier Cubero more than expected).

Fields of papers citing papers by Francisco Javier Cubero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco Javier Cubero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Javier Cubero. The network helps show where Francisco Javier Cubero may publish in the future.

Co-authorship network of co-authors of Francisco Javier Cubero

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco Javier Cubero. A scholar is included among the top collaborators of Francisco Javier Cubero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco Javier Cubero. Francisco Javier Cubero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pérez-Lanzón, María, et al.. (2026). Identification of ACBP as a potential target in ciliopathic obesity through multi-omics network analysis. Nature Communications. 17(1). 362–362.

Villanueva‐Paz, Marina, Hao Niu, Ismael Álvarez‐Álvarez, et al.. (2024). Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network. Journal of Hepatology. 81(4). 630–640. 6 indexed citations

Nevzorova, Yulia A. & Francisco Javier Cubero. (2024). Seladelpar: New hope for patients with primary biliary cholangitis. Med. 5(5). 377–379. 1 indexed citations

Sanz‐García, Carlos, Yulia A. Nevzorova, Eduardo Martı́nez-Naves, et al.. (2023). Novel therapeutic avenues for the study of chronic liver disease and regeneration: The foundation of the Iberoamerican Consortium for the study of liver Cirrhosis. Gastroenterología y Hepatología (English Edition). 46(4). 322–328.

Benedé‐Ubieto, Raquel, Ricardo Ulises Macías‐Rodríguez, Astrid Ruiz‐Margáin, et al.. (2021). Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain. Journal of Clinical Medicine. 10(5). 1039–1039. 15 indexed citations

Chen, Chaobo, et al.. (2021). Fibrotic Events in the Progression of Cholestatic Liver Disease. Cells. 10(5). 1107–1107. 36 indexed citations

Fernández‐Iglesias, Anabel, Félix Royo, Mikel Azkargorta, et al.. (2021). Transcriptomic Profiling of the Liver Sinusoidal Endothelium during Cirrhosis Reveals Stage-Specific Secretory Signature. Cancers. 13(11). 2688–2688. 27 indexed citations

Sanz‐García, Carlos, Anabel Fernández‐Iglesias, Jordi Gracia‐Sancho, et al.. (2021). The Space of Disse: The Liver Hub in Health and Disease. MDPI (MDPI AG). 1(1). 3–26. 29 indexed citations

Atallah, Edmond, Ismael Álvarez‐Álvarez, Francisco Javier Cubero, et al.. (2021). Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review. Expert Opinion on Drug Metabolism & Toxicology. 17(11). 1327–1343. 12 indexed citations

10.

Zoubek, Miguel Eugenio, Dennis Doleschel, Matthias Bartneck, et al.. (2020). Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease. Cell Death and Disease. 11(5). 343–343. 37 indexed citations

11.

Macías‐Rodríguez, Ricardo Ulises, María Eugenia Inzaugarat, Astrid Ruiz‐Margáin, et al.. (2020). Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis—A Novel Form of Non-Apoptotic Cell Death?. International Journal of Molecular Sciences. 21(5). 1651–1651. 83 indexed citations

12.

Benedé‐Ubieto, Raquel, et al.. (2020). <p>Guidelines and Considerations for Metabolic Tolerance Tests in Mice</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 439–450. 106 indexed citations

13.

Nevzorova, Yulia A., Zoe Boyer‐Díaz, Francisco Javier Cubero, & Jordi Gracia‐Sancho. (2020). Animal models for liver disease – A practical approach for translational research. Journal of Hepatology. 73(2). 423–440. 173 indexed citations

14.

Manieri, Elisa, Alfonso Mora, Antonia Tomás‐Loba, et al.. (2019). Adiponectin accounts for gender differences in hepatocellular carcinoma incidence. The Journal of Experimental Medicine. 216(5). 1108–1119. 75 indexed citations

15.

Ramadori, Pierluigi, Francisco Javier Cubero, Christian Liedtke, Christian Trautwein, & Yulia A. Nevzorova. (2017). Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame. Cancers. 9(10). 130–130. 50 indexed citations

16.

Zheng, Kang, Francisco Javier Cubero, & Yulia A. Nevzorova. (2017). c-MYC—Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease. Genes. 8(4). 123–123. 60 indexed citations

17.

Mohs, Antje, Kim Ohl, Guido Hooiveld, et al.. (2016). Hepatic overexpression of cAMP-responsive element modulator α induces a regulatory T-cell response in a murine model of chronic liver disease. Gut. 66(5). 908–919. 12 indexed citations

18.

Zhao, Gang, Maximilian Hatting, Yulia A. Nevzorova, et al.. (2013). Jnk1 in murine hepatic stellate cells is a crucial mediator of liver fibrogenesis. Gut. 63(7). 1159–1172. 46 indexed citations

19.

Arriazu, Elena, Marina Ruiz de Galarreta, Francisco Javier Cubero, et al.. (2013). Extracellular Matrix and Liver Disease. Antioxidants and Redox Signaling. 21(7). 1078–1097. 135 indexed citations

20.

Liedtke, Christian, Jörg‐Martin Bangen, Julia Freimuth, et al.. (2011). Loss of Caspase-8 Protects Mice Against Inflammation-Related Hepatocarcinogenesis but Induces Non-Apoptotic Liver Injury. Gastroenterology. 141(6). 2176–2187. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact